Skip to main
STML
STML logo

Stemline Therapeutics (STML) Earnings Dates & Reports

Stemline Therapeutics (STML) Most Recent Earnings

Report DateMar 13, 2020
Period EndingQ4 2019
Est. EPS-$0.35
Actual EPS-$0.38
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Stemline Therapeutics (STML) Earnings per Share (EPS) History

Signup for full access
Browse free

Stemline Therapeutics (STML) Latest Earnings

The value each STML share was expected to gain vs. the value each share gained.

Stemline Therapeutics (STML) reported its most recent earnings on Mar 13, 2020 for Q4 2019, posting earnings per share (EPS) of -$0.38. This exceeded analysts' expectations of -$0.35 by 8.57%, marking a Miss.

For comparison, Stemline Therapeutics reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 03/13/2020, with analysts projecting an EPS of $0.

Stemline Therapeutics (STML) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2019Mar 13, 2020
-$0.35-$0.38+8.57%
DeckReportListen

Stemline Therapeutics (STML) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Stemline Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Stemline Therapeutics (STML) Earnings FAQs

Stemline Therapeutics (STML) last reported earnings on Mar 13, 2020 for Q4 2019, posting an EPS of -$0.38, which Miss the estimate of -$0.35 by 8.57%.

For Q4 2019, Stemline Therapeutics (STML) reported an EPS of -$0.38, missing analysts' estimate of -$0.35 by 8.57%.

For Q4 2019, Stemline Therapeutics (STML) Miss expectations with an actual EPS of -$0.38 vs. an estimated EPS of -$0.35.

Following the last earnings report on Mar 13, 2020, Stemline Therapeutics (STML)'s stock price moved — from — to —.

The next Stemline Therapeutics (STML) earnings call is scheduled for Mar. 13, 2020, where executives will discuss financial results and outlook.

Stemline Therapeutics (STML)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.